Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

fifififif

Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA

August 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Working Life, feature

“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
Feature
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

August 26, 2020 Research and Development COVID, COVID-19, coronavirus

In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that …
News
gilead-sciences

FDA turns down Gilead’s JAK inhibitor filgotinib in rheumatoid arthritis, endangering 2020 approval hopes

August 20, 2020 Research and Development, Sales and Marketing FDA, Gilead, filgotinib

Gilead’s JAK inhibitor filgotinib has been unexpectedly knocked back by the FDA as a therapy to treat moderately to severely …
News
fda_21

FDA delays BioMarin’s gene therapy for haemophilia A

August 20, 2020 Research and Development, Sales and Marketing FDA

The FDA has delayed Roctavin, BioMarin’s gene therapy for haemophilia A, by a year to wait for more extensive results, …
News
merckincweb2

MSD unveils plans for $1.3bn central London research centre

August 19, 2020 Manufacturing and Production, Research and Development London, MSD, pharma

MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …
News
sydney

Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidate

August 19, 2020 Research and Development AstraZeneca, Australia, COVID-19, pharma

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …
News
800px-temazepam_10mg_tablets-1

US states seek $26.4 billion from major pharmaceutical manufacturers and distributors to settle opioid litigation

August 19, 2020 Research and Development opioid crisis, opioid epidemic, opioids

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major …
News
bojo

UK Government officially announces National Institute for Health Protection to replace Public Health England

August 19, 2020 Research and Development opioid, opioid crisis, opioid epidemic

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection. …
News
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

August 19, 2020 Research and Development coronavirus, top 10

Potentially unsafe coronavirus treatments are in the headlines this week, as President Donald Trump reportedly wants to approve Phoenix Biotechnology’s …
News
fda

Poseida suspends CAR T therapy trial in prostate cancer due to patient death

August 18, 2020 Manufacturing and Production, Research and Development CAR T, CAR-T, Poseida, patient death, pharma

Poseida’s Phase 1 trial that used an investigational CAR T therapy for treating prostate cancer has been suspended due to …
News
trummmuuuue

Trump allegedly “enthusiastic” for oleandrin to be approved as a COVID-19 treatment

August 18, 2020 Manufacturing and Production, Research and Development coronavirus vaccine, covid19

President Donald Trump reportedly wants to approve Phoenix Biotechnology’s oleandrin as a coronavirus treatment, despite a lack of evidence for …
News
cbdx

NHS guidelines on prescription cannabis to be challenged in court

August 18, 2020 Manufacturing and Production, Research and Development CBD, cannabis, epilepsy

The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …
News

MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures

August 13, 2020 Research and Development MHRA, cenobamate, seizures

Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
News
shutterstock_158366573

Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues

August 12, 2020 Research and Development COVID-19, Gilead, pharma, remdesivir

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
News
bristol_myers_squibb

Bristol Myers Squibb announces positive results from Opdivo clinical trials

August 12, 2020 Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb

Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026